Literature DB >> 23111952

Natural killer cells in liver disease.

Zhigang Tian1, Yongyan Chen, Bin Gao.   

Abstract

Natural killer (NK) cells are enriched in lymphocytes within the liver and have unique phenotypic features and functional properties, including tumor necrosis factor-related apoptosis-inducing ligand-dependent cytotoxicity and specific cytokine profiles. As a key component of innate immunity in the liver, NK cells perform critical roles in host defense against pathogens and tumors through their natural cytotoxicity and cytokine production, and they also act as regulatory cells by engaging in reciprocal interactions with other types of liver cells through cell-to-cell contact and the production of cytokines. Accumulating evidence from the last decade suggests that NK cells play an important role in controlling viral hepatitis, liver fibrosis, and liver tumorigenesis, but also contribute to the pathogenesis of liver injury and inflammation. The characterization of intrahepatic NK cell functions has not only helped us to better understand the pathogenesis of liver disease, but has also revealed new therapeutic targets for managing this disease.
Copyright © 2012 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23111952      PMCID: PMC3573257          DOI: 10.1002/hep.26115

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  80 in total

1.  Dendritic cells regulate natural killer cell activation and epithelial injury in experimental biliary atresia.

Authors:  Vijay Saxena; Pranavkumar Shivakumar; Gregg Sabla; Reena Mourya; Claire Chougnet; Jorge A Bezerra
Journal:  Sci Transl Med       Date:  2011-09-28       Impact factor: 17.956

2.  Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection.

Authors:  Kerstin A Stegmann; Niklas K Björkström; Heike Veber; Sandra Ciesek; Peggy Riese; Johannes Wiegand; Johannes Hadem; Pothakamuri V Suneetha; Jerzy Jaroszewicz; Chun Wang; Verena Schlaphoff; Paraskevi Fytili; Markus Cornberg; Michael P Manns; Robert Geffers; Thomas Pietschmann; Carlos A Guzmán; Hans-Gustaf Ljunggren; Heiner Wedemeyer
Journal:  Gastroenterology       Date:  2010-02-02       Impact factor: 22.682

3.  Post-natal paucity of regulatory T cells and control of NK cell activation in experimental biliary atresia.

Authors:  Alexander G Miethke; Vijay Saxena; Pranavkumar Shivakumar; Gregg E Sabla; Julia Simmons; Claire A Chougnet
Journal:  J Hepatol       Date:  2010-03-05       Impact factor: 25.083

4.  Suppression of innate immunity (natural killer cell/interferon-γ) in the advanced stages of liver fibrosis in mice.

Authors:  Won-Il Jeong; Ogyi Park; Yang-Gun Suh; Jin-Seok Byun; So-Young Park; Earl Choi; Ja-Kyung Kim; Hyojin Ko; Hua Wang; Andrew M Miller; Bin Gao
Journal:  Hepatology       Date:  2011-04       Impact factor: 17.425

5.  NK cells suppress experimental cholestatic liver injury by an interleukin-6-mediated, Kupffer cell-dependent mechanism.

Authors:  Chao-Wen Cheng; Caroline C Duwaerts; Nico van Rooijen; Philip Wintermeyer; Stephanie Mott; Stephen H Gregory
Journal:  J Hepatol       Date:  2010-11-18       Impact factor: 25.083

6.  Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C.

Authors:  Golo Ahlenstiel; Birgit Edlich; Leah J Hogdal; Yaron Rotman; Mazen Noureddin; Jordan J Feld; Lauren E Holz; Rachel H Titerence; T Jake Liang; Barbara Rehermann
Journal:  Gastroenterology       Date:  2011-07-07       Impact factor: 22.682

7.  Natural killer cells take two tolls to destruct bile ducts.

Authors:  Bin Gao; Adeline Bertola
Journal:  Hepatology       Date:  2011-04       Impact factor: 17.425

8.  Interaction between Toll-like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosis.

Authors:  Shinji Shimoda; Kenichi Harada; Hiroaki Niiro; Ken Shirabe; Akinobu Taketomi; Yoshihiko Maehara; Koichi Tsuneyama; Yasuni Nakanuma; Patrick Leung; Aftab A Ansari; M Eric Gershwin; Koichi Akashi
Journal:  Hepatology       Date:  2011-03-11       Impact factor: 17.425

9.  Genomic modeling of tumor onset and progression in a mouse model of aggressive human liver cancer.

Authors:  Cédric Coulouarn; Valentina M Factor; Elizabeth A Conner; Snorri S Thorgeirsson
Journal:  Carcinogenesis       Date:  2011-07-18       Impact factor: 4.944

10.  Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease.

Authors:  Wing-Kin Syn; Ye Htun Oo; Thiago A Pereira; Gamze F Karaca; Youngmi Jung; Alessia Omenetti; Rafal P Witek; Steve S Choi; Cynthia D Guy; Caitlin M Fearing; Vanessa Teaberry; Fausto E L Pereira; David H Adams; Anna Mae Diehl
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

View more
  112 in total

1.  Toll-Like receptor 2 (TLR2) and TLR9 play opposing roles in host innate immunity against Salmonella enterica serovar Typhimurium infection.

Authors:  Renhui Zhan; Qiuju Han; Cai Zhang; Zhigang Tian; Jian Zhang
Journal:  Infect Immun       Date:  2015-02-09       Impact factor: 3.441

2.  The pro-fibrotic role of dipeptidyl peptidase 4 in carbon tetrachloride-induced experimental liver injury.

Authors:  Xin M Wang; Lauren E Holz; Sumaiya Chowdhury; Shaun P Cordoba; Kathryn A Evans; Margaret G Gall; Ana Júlia Vieira de Ribeiro; Yuan Zhou Zheng; Miriam T Levy; Denise Mt Yu; Tsun-Wen Yao; Natasa Polak; Christopher J Jolly; Patrick Bertolino; Geoffrey W McCaughan; Mark D Gorrell
Journal:  Immunol Cell Biol       Date:  2016-11-30       Impact factor: 5.126

3.  Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model.

Authors:  Kun-Yu Teng; Jianfeng Han; Xiaoli Zhang; Shu-Hao Hsu; Shun He; Nissar A Wani; Juan M Barajas; Linda A Snyder; Wendy L Frankel; Michael A Caligiuri; Samson T Jacob; Jianhua Yu; Kalpana Ghoshal
Journal:  Mol Cancer Ther       Date:  2016-12-15       Impact factor: 6.261

Review 4.  Location and cellular stages of natural killer cell development.

Authors:  Jianhua Yu; Aharon G Freud; Michael A Caligiuri
Journal:  Trends Immunol       Date:  2013-09-19       Impact factor: 16.687

5.  Liver-resident NK cells and their potential functions.

Authors:  Hui Peng; Rui Sun
Journal:  Cell Mol Immunol       Date:  2017-09-18       Impact factor: 11.530

Review 6.  Natural killer cells in hepatocellular carcinoma: current status and perspectives for future immunotherapeutic approaches.

Authors:  Min Yu; Zonghai Li
Journal:  Front Med       Date:  2017-08-05       Impact factor: 4.592

Review 7.  Modulators of innate immunity as novel therapeutics for treatment of chronic hepatitis B.

Authors:  Aleksei Suslov; Stefan Wieland; Stephan Menne
Journal:  Curr Opin Virol       Date:  2018-02-20       Impact factor: 7.090

Review 8.  Natural killer cells in liver diseases.

Authors:  Meijuan Zheng; Haoyu Sun; Zhigang Tian
Journal:  Front Med       Date:  2018-04-19       Impact factor: 4.592

Review 9.  The wound healing, chronic fibrosis, and cancer progression triad.

Authors:  Brad Rybinski; Janusz Franco-Barraza; Edna Cukierman
Journal:  Physiol Genomics       Date:  2014-02-11       Impact factor: 3.107

10.  Cultured Mycelium Cordyceps sinensis allevi¬ates CCl4-induced liver inflammation and fibrosis in mice by activating hepatic natural killer cells.

Authors:  Yuan Peng; Kai Huang; Li Shen; Yan-yan Tao; Cheng-hai Liu
Journal:  Acta Pharmacol Sin       Date:  2015-11-23       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.